希诺神州集团简介 COPORATION INTRODUKCTION
新公司:上海希诺神州生命健康科技股份有限公司成立于2021年12月，公司起源于北京汉氏联合生物技术股份有限公司大健康事业部。团队在大健康领域深耕十几年，具备从研发、运营到销售的超前布局和竞争优势。
New company:Shanghai Xinuo shenzhou Life and Health Technology Co., Ltd. was established in December 2021. The company originated from the Big Health Division of Beiing Hanshi United Biotechnology Co., Ltd. The team has been deeply involved in the field of big health for over a decade, possessing advanced layout and competitive advantages from research and development, operation to sales.
新定位:Artificial inteligence (Al)是科技创新企业未来发展必将涉足并深度挖掘的领域，因此希诺神州将大健康技术与AI技术做了有机融合。以大数据挖掘、算法和大模型为核心驱动力，着重为客户打造全生命周期数字智能化长寿健康管理2.0 版智能定制服务，在不久的将来集团将全面实现以衰老研究为驱动的身心美一体精准医学的综合服务平台。
New positioning:Artificial Inteligence (Al) is a field that technology innovation enterprises will inevitably enter and deeply explore in their future development. Therefore, Sinosure has organically integrated big health technology with Al technology. Driven by big data mining, algorithms, and big models, the group focuses on creating a full lifecycle digital intelligent longevity health management 2.0 version inteligent customized service for customers. in the near future, the group will fuly realize a comprehensive service platform for precision medicine that integrates body, mind, and beauty driven by aging research.
新发展:从2021年底成立之日起独立运营，成功被上海市招商引资入户宝山区。公司以严谨的科学态度、实事求是的经营理念、建设独特的现代化开放式企业文化，聚焦再生医学与大健康产业的创新升级。2022年起，公司在上海宝山区投资建设《综合性细胞生物医药产业基地》，立足上海，打造全国乃至全球具有影响力的生命科学创新中心。
New Developments:Since its establishment at the end of 2021,it has been independently operated and successfully attracted investment from Shanghai to enter Baoshan District. The company focuses on the innovation and upgrading of regeneraive medicine and the big health industry with a rigorous scientific atitude, a pragmatic business philosophy, and a unique modern open corporate culture. Starting from 2022,the company will invest in the construction of the "Comprehensive Cell Biopharmaceutical lndustry Base" in Baoshan District, Shanghai, with a focus on Shanghai and building a nationally and even globally influential life science innovation center.
新目标：希诺神州作为一家科技开放型企业，关注并在生物工程化技术(智能制造)、IVD检测技术，脑机科学、应用心理学以及大健康未病先防和疾病治疗的生物干预方案和服务等方面开拓创新和整合应用。公司自主研发了多个技术，获得了数十个发明、还有软件制作权。集团公司诚信、合作、开放的企业文化，希望在未来的发展道路上能与更多的伙伴合作。
New Goal:As a technology open enterprise, Sinopharm focuses on exploring innovative and integrated applications in biotechnology (intelligent manufacturing), lVD detection technology, brain computer science, applied psychology, and biological intervention programs and services for disease prevention and treatment in the field of big health. The company has independently developed multiple technologies,obtained dozens of inventions, and software production rights. The corporate culture of the group company is integrity, cooperation,and openness, and we hope to cooperate with more partners in the future development path.
新使命：希诺神州旗下三家全资子公司，上海汉氏方舟生物科技有限公司、北京希诺赛尔健康科技推广有限公司、上海赛尔须弥信息科技有限公司，共同承载着在全国建立面向终端客户的实体“科普中心”、“健康美学空间”及“生物信息大数据”的重要任务。科普中心从虚拟落地到实体，走进终端，走向大众，负责在全国范围内推广生命科学、身心全科大健康领域的先进科技技术，为终端大众提供一个首观,、高效的科技服务平台。
New mission:The three wholy-owned subsidiaries of Sinosure, Shanghai Hanshi Ark Biotechnoloey Co., Ltd., Beijing Sinosure Health Technology Promotion Co., Ltd., and Shanghai Seer Xumi lnformation Technology Co., Ltd., jointly undertake the important task of establishing physical "science popularization centers", "health aesthetics spaces", and "bioinformatics big data" for end customers nationwide. The Science Popularization Center is responsible for promoting advanced technology in the fields of life sciences and general health across the country, from virtual landing to physical implementation, entering terminals, and reaching the publc. it orovides an intultive and efficient technology service platform for the general public.